HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiuyan Ding Selected Research

Infections

2/2022β-Catenin-Specific Inhibitor, iCRT14, Promotes BoHV-1 Infection-Induced DNA Damage in Human A549 Lung Adenocarcinoma Cells by Enhancing Viral Protein Expression.
12/2021β-catenin has potential effects on the expression, subcellular localization, and release of high mobility group box 1 during bovine herpesvirus 1 productive infection in MDBK cell culture.
12/2021Potential effects of HMGB1 on viral replication and virus infection-induced inflammatory responses: A promising therapeutic target for virus infection-induced inflammatory diseases.
8/2021Oncolytic Bovine Herpesvirus 1 Inhibits Human Lung Adenocarcinoma A549 Cell Proliferation and Tumor Growth by Inducing DNA Damage.
1/2017The role of phospholipase C signaling in bovine herpesvirus 1 infection.
3/2016BHV-1 induced oxidative stress contributes to mitochondrial dysfunction in MDBK cells.
1/2016PLC-γ1 is involved in the inflammatory response induced by influenza A virus H1N1 infection.
4/2011Biphasic activation of PI3K/Akt and MAPK/Erk1/2 signaling pathways in bovine herpesvirus type 1 infection of MDBK cells.
7/2010Critical role of cholesterol in bovine herpesvirus type 1 infection of MDBK cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiuyan Ding Research Topics

Disease

9Infections
02/2022 - 07/2010
4Virus Diseases (Viral Diseases)
02/2022 - 01/2017
2Inflammation (Inflammations)
07/2017 - 01/2016
1Adenocarcinoma of Lung
02/2022
1Genomic Instability
02/2022
1Cytokine Release Syndrome
12/2021
1Disease Progression
12/2021
1Neoplasms (Cancer)
08/2021
1Diarrhea
07/2021

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
02/2022 - 03/2016
2CateninsIBA
02/2022 - 12/2021
2HMGB1 Protein (HMG1)IBA
12/2021 - 12/2021
1Viral ProteinsIBA
02/2022
1iCRT14IBA
02/2022
12,4-thiazolidinedione (thiazolidinedione)IBA
02/2022
1Glycoproteins (Glycoprotein)IBA
02/2022
1CytokinesIBA
12/2021
1Messenger RNA (mRNA)IBA
12/2021
1trichostatin A (A 300)IBA
08/2021
1Histone Deacetylases (Histone Deacetylase)IBA
08/2021
1Pharmaceutical PreparationsIBA
08/2021
1Histone Deacetylase InhibitorsIBA
08/2021
1theasinensin AIBA
08/2021
1Peptide LibraryIBA
07/2021
1B-Lymphocyte Epitopes (B-Cell Epitope)IBA
07/2021
1Phosphotransferases (Kinase)IBA
07/2017
1NF-kappa B (NF-kB)IBA
07/2017
1Type C PhospholipasesIBA
01/2017
1Matrix Metalloproteinases (MMPs)IBA
03/2016
1Adenosine Triphosphate (ATP)IBA
03/2016
1Reactive Oxygen Species (Oxygen Radicals)IBA
03/2016
1Phosphatidylinositols (Phosphatidylinositol)IBA
01/2016
1Phospholipases (Phospholipase)IBA
01/2016
1Antiviral Agents (Antivirals)IBA
01/2016
1Mitogen-Activated Protein Kinase 3IBA
04/2011
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
04/2011
1Mitogen-Activated Protein KinasesIBA
04/2011
1CholesterolIBA
07/2010

Therapy/Procedure

1Therapeutics
01/2016